Company

Tempus

vendor1 tracked tool

life_sciences_drug_discovery category intelligence

Tracked Tools by Tempus

Tempus is a precision medicine and health data analytics company that uses AI and machine learning to analyze clinical and molecular data at scale. The platform provides genomic profiling, AI-driven treatment matching, clinical trial matching, and one of the largest clinico-genomic databases in the world. Tempus serves oncologists, neurologists, and other specialists with actionable insights for personalized treatment decisions. Publicly traded on NASDAQ (TEM).

Company Intelligence

Tempus Reports First Quarter 2026 Results

2 days agoevidence

Clinical validation of the Tempus xO assay

4 days agoevidence

Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

5 days agostartup

NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay

5 days agoevidence

Northwestern Medicine Integrates Tempus AI’s “David” Clinical Assistant into EHR Platform

6 days agodeployment

FDA grants 510(k) clearance for Tempus AI’s ejection fraction software

6 days agofda

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

7 days agodeployment

Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology

7 days agodeployment

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

7 days agofda

Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs

7 days agofda

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

7 days agofda

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software

7 days agofda

Tempus Announces the Launch of Paige Predict

9 days agostartup

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

21 days agodeployment

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

a month agodeployment